Complete sustained regression of extensive psoriasis with cetuximab combination chemotherapy.
Trivin
Florence
F
Boucher
Eveline
E
Raoul
Jean-Luc
JL
D000368:Aged; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000494:pharmacology*; D000068818:Cetuximab; D003110:Colonic Neoplasms / Q000150:complications / Q000188:drug therapy*; D066246:ErbB Receptors / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab